The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 350:1912 April 29, 2004 Number 18
NextNext

State Initiatives to Control Medicaid Drug Costs

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Mello, M. M.
-PubMed Citation
To the Editor: Mello et al. (Feb. 5 issue)1 describe initiatives to control states' expenditures for drugs, including multiple mechanisms for forcing physicians to obtain approval to prescribe drugs. Physicians working to provide appropriate treatment thereby become grubbing middlemen between Medicaid and manufacturers, having to negotiate or plainly beg for coverage. Although the goal of prior-authorization programs is to reduce costs by eliminating inappropriate prescribing, the programs impede both inappropriate and appropriate prescribing. Physicians facing complex medical decisions in the small amount of time between visits must shift their attention to discuss indications for drugs with insurers. These clerical tasks . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.